CN108210878A - 补肾生精的虫草雪莲多糖复合物 - Google Patents
补肾生精的虫草雪莲多糖复合物 Download PDFInfo
- Publication number
- CN108210878A CN108210878A CN201810172024.3A CN201810172024A CN108210878A CN 108210878 A CN108210878 A CN 108210878A CN 201810172024 A CN201810172024 A CN 201810172024A CN 108210878 A CN108210878 A CN 108210878A
- Authority
- CN
- China
- Prior art keywords
- cordyceps sinensis
- parts
- saussurea
- kidney
- polysaccharide compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001248610 Ophiocordyceps sinensis Species 0.000 title claims abstract description 121
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 81
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 81
- -1 Polysaccharide compound Chemical class 0.000 title claims abstract description 53
- 241000133134 Saussurea Species 0.000 title claims abstract description 29
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 31
- 239000000843 powder Substances 0.000 claims abstract description 21
- 241000251511 Holothuroidea Species 0.000 claims abstract description 19
- 241000237502 Ostreidae Species 0.000 claims abstract description 19
- 235000020636 oyster Nutrition 0.000 claims abstract description 19
- 241001145025 Saussurea involucrata Species 0.000 claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 17
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 13
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 13
- 239000004615 ingredient Substances 0.000 claims abstract description 11
- 235000013305 food Nutrition 0.000 claims abstract description 9
- 230000036541 health Effects 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 5
- 150000004676 glycans Chemical class 0.000 claims description 29
- 241000190633 Cordyceps Species 0.000 claims description 16
- 239000012141 concentrate Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- 241001264174 Cordyceps militaris Species 0.000 claims description 6
- 241000233866 Fungi Species 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 3
- 241000382353 Pupa Species 0.000 claims description 2
- 240000006698 Spigelia anthelmia Species 0.000 claims description 2
- 230000003071 parasitic effect Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- 239000002994 raw material Substances 0.000 abstract description 9
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 230000003907 kidney function Effects 0.000 abstract description 3
- 230000035622 drinking Effects 0.000 abstract description 2
- 235000008216 herbs Nutrition 0.000 abstract description 2
- 230000010354 integration Effects 0.000 abstract description 2
- 230000021595 spermatogenesis Effects 0.000 abstract description 2
- 238000000034 method Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000000605 extraction Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000001568 sexual effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 244000025254 Cannabis sativa Species 0.000 description 4
- 240000001307 Myosotis scorpioides Species 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 210000004907 gland Anatomy 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000003679 aging effect Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 150000003333 secondary alcohols Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- VZQHRKZCAZCACO-PYJNHQTQSA-N (2s)-2-[[(2s)-2-[2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]prop-2-enoylamino]-3-methylbutanoyl]amino]propanoic acid Chemical group OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VZQHRKZCAZCACO-PYJNHQTQSA-N 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000021663 Female sexual arousal disease Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000134540 Polymnia sonchifolia Species 0.000 description 1
- 235000003406 Polymnia sonchifolia Nutrition 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000006262 Psychological Sexual Dysfunctions Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000002508 compound effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000001856 erectile effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000006025 fining agent Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000018648 unbalanced nutrition Nutrition 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了补肾生精的虫草雪莲多糖复合物,补肾生精的虫草雪莲多糖复合物,包括以下重量份数的成分:虫草多糖复合物45‑55份、牡蛎肽8‑12份、黄精提取物8‑12份、鹿肉粉6‑10份、雪莲6‑8份、海参肽4‑8份、枸杞8‑10份,余量为医用或食品保健用辅料。本发明通过虫草多糖复合物的特殊性,实现黄精,牡蛎肽,鹿肉粉,雪莲和海参肽功效的进一步增强;用虫草多糖复合物配伍牡蛎肽,枸杞,黄精,鹿肉粉,雪莲和海参肽以达到滋阴补肾,生精功能,在实践中,有效补肾生精,增强男女肾功能,提升男女性能力。而且本发明采用药食同源的原料,采用安全级别最高,即可以不限制用量的食品类原料进行合理配伍,兼具功效和安全性,无副作用,且无剂量限值。
Description
技术领域
本发明涉及一种补肾生精的虫草雪莲多糖复合物。
背景技术
虫草中所含有的虫草多糖是虫草体内含量最丰富、最重要的生物活性物质之一,具有广泛药理作用。近年来资源日益衰竭,人们尝试培养虫草菌丝体、子实体作天然虫草的替代,已经获得不同程度的认可。国家一类新药虫草菌粉,系采用从天然虫草中分离出虫草菌种,人工培养液体发酵和固体培养制成。
蛹虫草为子囊菌门,肉座目,虫草菌科、虫草属的模式种,又名北冬虫夏草、北虫草等。蛹虫草目前已实现人工栽培。虫草素、虫草酸和虫草多糖复合物是冬虫夏草菌特有的物质,是冬虫夏草特殊功效的主要指标。而恰恰是这些指标,在人工环境优裕条件下生长的北冬虫夏草含量可以比天然条件下生长得更高。人工培养的北冬虫夏草的蛋白质、氨基酸、维生素等含量均达到或超过天然冬虫夏草的水平。虽然人工培养的北冬虫夏草中的个别营养成分略低于天然冬虫夏草水平,但这些营养成分是可以通过研究加以提高的。
随着虫草传统功效不断地发掘,特别是虫草成份对应的药理研究和临床疗效果都得到了消费者的肯定,以虫草为原料的药品和保食品、保健品逐步开发并进入市场。根据国家食品药品监督管理局数据查询的结果,国产虫草保健食品大部分是原草或培育虫草直接销售,或是进行打粉、压片等粗加工销售,以单纯虫草制成的保健食品供应有两项弊端。
一是考虑到虫草价格昂贵,单品达到同样效果日服用剂量较大,产品价格较高,而令普通消费者难以承受;
二是没有基于中医基础理论,通过中药君、臣配伍发挥其最大效果,而使保健效能更为突出。
目前市场上多以简单的虫草鲜草、干草原材料进行销售,虫草深加工产品种类比较单一且数量少,虫草成份市场大部分走向高端医药产品为主,严重制约了虫草组合的附加价值和经济效益。且现有虫草饮品配方生产工艺不够合理,使得活性成分被破坏,营养物质损失过多,营养不均衡、保健作用不明显;另外在产品生产过程中添加过多辅料,如蔗糖、防腐剂、人工色素等,有损消费者身体健康,无法满足消费者滋补养生的需求。
发明内容
本发明针对上述问题,提出了一种虫草多糖复合物,雪莲、鹿肉粉、海参肽、牡蛎肽的配伍,以解决了现有技术虫草产品的缺陷,达到以虫草多糖复合物为君份主导、牡蛎肽为臣份铺助、配以雪莲、鹿肉粉、海参肽、黄精、枸杞组合而成,协同增效,补肾生精,增强人体肾功能的目的。
本发明采取的技术方案如下:
本发明提供一种补肾生精的虫草雪莲多糖复合物,包括以下重量份数的成分:
虫草多糖复合物45-55份、牡蛎肽8-12份、黄精提取物8-12份、鹿肉粉6-10份、雪莲6-8份、海参肽4-8份、枸杞8-10份,余量为医用或食品保健用辅料,
所述虫草多糖复合物包括虫草多糖和虫草基础成分,其中所述虫草基础成分选自下列之一:
虫草粉或虫草发酵菌丝体的提取物或浓缩物;
其中虫草为虫草属真菌寄生并能产生子实体的菌物结合体,包括冬虫夏草,蛹虫草及虫草属的其他种。
进一步,所述虫草为蛹虫草。
进一步,所述虫草多糖利用蛹虫草提取的多糖或者液体发酵培养蛹虫草菌丝体,然后从发酵液中提取虫草多糖进行纯化。
进一步,所述虫草多糖复合物中虫草多糖的质量分数为20%-35%。
进一步,所述补肾生精的虫草雪莲多糖复合物由以下重量份数的成分组成:虫草多糖复合物50份、牡蛎肽10份、黄精提取物10份、鹿肉粉8份、雪莲7份、海参肽6份、枸杞9份。
进一步,所述虫草多糖复合物中虫草多糖的质量分数为30%。
进一步,所述虫草雪莲多糖复合物制成片剂。
本发明还提供一种上述补肾生精的虫草雪莲多糖复合物在制备补肾生精的药物/食品/保健品中的应用。
与现有技术相比,本发明的有益效果是:
本发明以虫草多糖复合物为君份主导、牡蛎肽为臣份铺助、配以黄精、枸杞组合而成,协同增效,在虫草所含有效成分作为配方基础,实现两者的协同效果。在虫草有效成分基础配方中加上高含量多糖的复合配方的重复价值是对人体的疾病预防、治疗、延年益寿更精准、更高效、更合理和均衡。在实践中纯粹的多糖高含量也远未达到上述预期目标,而发明人经过多年研究和实践发现,达到最高阀值的虫草基础有效成份(或者浓缩基础有效成份)配上高含量多糖时对人类疾病的预防、治疗、延年益寿达到最佳效果。而且虫草多糖复合物可以增强人体对其他物质的吸收效果,从而提升其他成分的功效。
而且虫草多糖复合物可以增强人体对其他物质的吸收效果,从而提升其他成分的功效。
牡蛎的营养成分有、钙、铁、磷、镁、锰、钠、锌、硒、铜、维生素B2与同类食物相比高于平均值,黄精富含蛋白质、锌、欧米伽3脂肪酸及酪氨酸,胆固醇含量低。具有能量供给、维护机能平衡等有着多方面功能功效。而牡蛎肽保留了牡蛎原有的维生素、微量元素和牛磺酸等营养成份,而且使富含核酸的牡蛎在人体摄入后比单一氨基酸或蛋白质吸收更快,更容易被肌体吸收,在人体代谢方面有着更重要的生物活性,可以有效提高男性血清睾酮水平。
本发明中加入的黄精作为传统中药,临床具有补气养阴,健脾,润肺,益肾功能。用于治疗脾胃虚弱,体倦乏力,口干食少,肺虚燥咳,精血不足,内热消渴等症。
枸杞补肾益精,养肝明目,补血安神,生津止渴,润肺止咳。于调理肝肾阴亏,腰膝酸软,头晕,目眩,目昏多泪,虚劳咳嗽,消渴,遗精。
鹿肉粉对失眠盗汗,内脏积水引起心跳、心慌等症有显效,治肺痿吐血。治阳痿、早泄、腰痛、形寒肢冷,妇人***、头晕、目眩、精神不振等症。
雪莲含有多种对人体机能的有益成份,它能对人体起到极好的调理和保健作用雪莲含有丰富的蛋白质和氨基酸,可有交地调节人体酸碱度,增强人体免疫力及抗疲劳。雪莲具有强心作用,对子宫具有强大的选择性兴奋作用,对风湿类风湿及肾虚引起的腰膝酸痛,性功能衰退,妇女***,痛经,崩漏均有很好的疗效。
海参含有非常丰富的精氨酸,被称为是精氨酸种的大富翁。而精氨酸则是组成男性***的重要主成成份。它不但具有改善脑和性腺的神经功能的传导作用,还具有明显的缓解性腺衰老的作用,从而提高男性***的能力。并且有抑制***和刺激宫缩作用,能改善脑、性腺神经功能传导作用,延缓性腺衰老等功效,抗疲劳、抗衰老、补益肾精,壮阳作用及其明显。
本发明通过虫草多糖复合物的特殊性,实现黄精,牡蛎肽,鹿肉粉,雪莲和海参肽功效的进一步增强;用虫草多糖复合物配伍牡蛎肽,枸杞,黄精,鹿肉粉,雪莲和海参肽以达到滋阴补肾,生精功能,在实践中,有效补肾生精,增强男女肾功能,提升男女性能力。而且本发明采用药食同源的原料,采用安全级别最高,即可以不限制用量的食品类原料进行合理配伍,兼具功效和安全性,无副作用,且无剂量限值。
具体实施方式:
下面结合具体实施例,对本发明做详细描述。
实施例1
补肾生精的虫草雪莲多糖复合物
取虫草菌丝体,液态发酵法进行培养,培养5天后,提取培养物中的虫草多糖,提取方法采用现有技术即可,得到虫草粗多糖。然后对虫草粗多糖进行提纯,获得纯度大于90%的虫草多糖。
另取虫草菌丝体培养物进行浓缩,浓缩10倍后得到虫草培养液浓缩物,按重量百分数,30%的虫草多糖,70%的虫草培养液浓缩物配置虫草多糖复合物。
实施例2
黄精提取物的制备工艺:黄精→前处理→提取→浓缩→加醇静置冷却→过滤,浓缩→二次醇沉→浓缩→喷雾干燥→包装灭菌→成品
具体步骤
1、前处理:将黄精挑拣,切碎投至提取罐中浸泡3h。
2、提取:加入3倍量纯水,第一次回流提取3h,从溶媒沸腾计时,控制温度100℃,保温到时。压出药液,第二次再加入3倍量纯水回流提取2h。第三次再加入2倍量纯水回流提取1h。
3、浓缩:将提取的药液抽入浓缩罐中进行减压浓缩,温度控制在70℃以下,真空度控制在0.06Mpa以上,将浸膏压入储液罐冷却。
4、醇沉、静置:注入3倍量的95%酒精的搅拌静置2h。
5、过滤:将静置后的上清醇液分离,过滤掉醇液得稀浸膏,浓缩。
6、二次醇沉:将稠膏用3倍量的80%酒精溶解,倾去上清液。
7、浓缩:将过滤后的药液进行浓缩,浓成稠膏。
8、喷雾干燥:将稠膏进行喷雾,水分<20%。
实施例3
鹿肉粉
取新鲜鹿肉洗净、脱水、初步绞碎,装入具有双层壁的蒸煮罐中,用蒸汽间接加热分离出油脂,然后将固体部分适当粉碎,用压榨法分离残留油脂,再将固体部分干燥后粉碎至粉。
实施例4
雪莲
人工种植的新鲜雪莲果原料经过洗涤—去皮—切块,热水磨浆—榨汁,添加天然澄清剂沉淀蛋白质、重金属离子、果胶、单宁、农残等杂质,再过滤分离、浓缩得到棕黄色雪莲果浓缩原汁,干燥后得棕黄色雪莲果汁原粉。
实施例5
海参肽
1、选用纯天然的海参使用低温剪切技术将物料在低温的条件性完成剪切过程;
2、真空超声波反应釜对海参肠卵混合流体进行处理;
3、采用温和的使用蛋白酶吸附法脱腥支除萜烯类化合物、胺类物质及吡啶类物质;
4、用180~220目的过滤器过滤得海参肠卵活性多肽液;
5、真空冷冻干燥。
实施例5
称取实施例1-4中各原料(未提及原料选用普通市场购买即可),按以下质量分数配置补肾生精的虫草雪莲多糖复合物:
虫草多糖复合物45份、牡蛎肽12份、黄精提取物10份、鹿肉粉6份、雪莲6份、海参肽8份、枸杞10份,麦芽糊精3份,得到补肾生精的虫草雪莲多糖复合物。
实施例6
补肾生精的虫草雪莲多糖复合物
取蛹虫草菌丝体,液态发酵法进行培养,培养8天后,提取培养物中的虫草多糖,提取方法采用现有技术即可。本实施例选择用水提法提取,得到虫草粗多糖。然后对虫草粗多糖进行提纯,获得纯度大于95%的虫草多糖。
另取蛹虫草菌丝体培养物进行浓缩,浓缩10倍后得到虫草培养液浓缩物,按重量百分数,30%的虫草多糖,70%的虫草培养液浓缩物配置虫草多糖复合物。
按以下重量份数配置补肾生精的虫草雪莲多糖复合物:
虫草多糖复合物55份、牡蛎肽8份、黄精提取物8份、鹿肉粉10份、雪莲6份、海参肽4份、枸杞9份,得到补肾生精的虫草雪莲多糖复合物。
实施例7
补肾生精的虫草雪莲多糖复合物
取蛹虫草菌丝体,液态发酵法进行培养,培养10天后,提取培养物中的虫草多糖,提取方法采用现有技术即可。本实施例选择用水提法提取,得到虫草粗多糖。然后对虫草粗多糖进行提纯,获得纯度大于99%的虫草多糖复。
另取蛹虫草菌丝体培养物进行浓缩,浓缩10倍后得到虫草培养液浓缩物,按重量百分数,35%的虫草多糖,65%的虫草培养液浓缩物配置虫草多糖复合物。
按以下重量份数配置补肾生精的虫草雪莲多糖复合物:
虫草多糖复合物50份、牡蛎肽10份、黄精提取物10份、鹿肉粉8份、雪莲7份、海参肽6份、枸杞9份,得到补肾生精的虫草雪莲多糖复合物。配制后压片制成片剂。
以上所述仅为本发明的优选实施例,并非因此即限制本发明的专利保护范围,凡是运用本发明说明书内容所作的等效变换,直接或间接运用在其他相关的技术领域,均同理包括在本发明的保护范围内。
Claims (7)
1.补肾生精的虫草雪莲多糖复合物,其特征在于,所述虫草雪莲多糖复合物包括以下重量份数的成分:
虫草多糖复合物45-55份、牡蛎肽8-12份、黄精提取物8-12份、鹿肉粉6-10份、雪莲6-8份、海参肽4-8份、枸杞8-10份,余量为医用或食品保健用辅料,
所述虫草多糖复合物包括虫草多糖和虫草基础成分,其中所述虫草基础成分选自下列之一:
虫草粉或虫草发酵菌丝体的提取物或浓缩物;
其中虫草为虫草属真菌寄生并能产生子实体的菌物结合体,包括冬虫夏草,蛹虫草及虫草属的其他种。
2.如权利要求1所述的补肾生精的虫草雪莲多糖复合物,其特征在于,所述虫草为蛹虫草。
3.如权利要求2所述的补肾生精的虫草雪莲多糖复合物,其特征在于,所述虫草多糖利用蛹虫草提取的多糖或者液体发酵培养蛹虫草菌丝体,然后从发酵液中提取虫草多糖进行纯化。
4.如权利要求2所述的补肾生精的虫草雪莲多糖复合物,其特征在于,所述虫草多糖复合物中虫草多糖的质量分数为20%-35%。
5.如权利要求1所述的补肾生精的虫草雪莲多糖复合物,其特征在于,所述补肾生精的虫草雪莲多糖复合物由以下重量份数的成分组成:虫草多糖复合物50份、牡蛎肽10份、黄精提取物10份、鹿肉粉8份、雪莲7份、海参肽6份、枸杞9份。
6.如权利要求5所述的补肾生精的虫草雪莲多糖复合物,其特征在于,所述虫草多糖复合物中虫草多糖的质量分数为30%。
7.如权利要求1-6任意一项所述的补肾生精的虫草雪莲多糖复合物,其特征在于,所述虫草雪莲多糖复合物制成片剂。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710631750 | 2017-07-28 | ||
CN2017106317502 | 2017-07-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108210878A true CN108210878A (zh) | 2018-06-29 |
Family
ID=62662395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810172024.3A Pending CN108210878A (zh) | 2017-07-28 | 2018-03-01 | 补肾生精的虫草雪莲多糖复合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108210878A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109043105A (zh) * | 2018-08-06 | 2018-12-21 | 佗鹊堂国投生物科技股份有限公司 | 补肾生精的虫草海参肽压片糖果 |
CN109077954A (zh) * | 2018-08-06 | 2018-12-25 | 佗鹊堂国投生物科技股份有限公司 | 虫草面膜 |
CN111357984A (zh) * | 2020-03-23 | 2020-07-03 | 李永红 | 一种润肺滋肾的营养组合物 |
CN111418849A (zh) * | 2020-04-22 | 2020-07-17 | 济南盘龙医药科技有限公司 | 一种适合提高机体组织细胞活性的营养制品 |
CN111657501A (zh) * | 2020-05-14 | 2020-09-15 | 中国海洋大学 | 一种具有增强免疫力功能的牡蛎肽虫草菌丝体组合物及其应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101947290A (zh) * | 2010-10-12 | 2011-01-19 | 郭景龙 | 一种具有滋阴作用的药物 |
CN104855778A (zh) * | 2015-05-29 | 2015-08-26 | 傅春华 | 一种补肾滋阴多糖及其制备工艺 |
CN106539079A (zh) * | 2016-11-27 | 2017-03-29 | 威海蓝印海洋生物科技有限公司 | 一种海洋生物保健食品及其制备方法 |
CN106913854A (zh) * | 2017-01-22 | 2017-07-04 | 楼良水 | 虫草多糖蛋白肽复合物及其应用 |
CN106943586A (zh) * | 2017-03-31 | 2017-07-14 | 山东岐伯堂生物科技有限公司 | 一种男性保健壮阳制剂生产方法 |
-
2018
- 2018-03-01 CN CN201810172024.3A patent/CN108210878A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101947290A (zh) * | 2010-10-12 | 2011-01-19 | 郭景龙 | 一种具有滋阴作用的药物 |
CN104855778A (zh) * | 2015-05-29 | 2015-08-26 | 傅春华 | 一种补肾滋阴多糖及其制备工艺 |
CN106539079A (zh) * | 2016-11-27 | 2017-03-29 | 威海蓝印海洋生物科技有限公司 | 一种海洋生物保健食品及其制备方法 |
CN106913854A (zh) * | 2017-01-22 | 2017-07-04 | 楼良水 | 虫草多糖蛋白肽复合物及其应用 |
CN106943586A (zh) * | 2017-03-31 | 2017-07-14 | 山东岐伯堂生物科技有限公司 | 一种男性保健壮阳制剂生产方法 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109043105A (zh) * | 2018-08-06 | 2018-12-21 | 佗鹊堂国投生物科技股份有限公司 | 补肾生精的虫草海参肽压片糖果 |
CN109077954A (zh) * | 2018-08-06 | 2018-12-25 | 佗鹊堂国投生物科技股份有限公司 | 虫草面膜 |
CN111357984A (zh) * | 2020-03-23 | 2020-07-03 | 李永红 | 一种润肺滋肾的营养组合物 |
CN111418849A (zh) * | 2020-04-22 | 2020-07-17 | 济南盘龙医药科技有限公司 | 一种适合提高机体组织细胞活性的营养制品 |
CN111657501A (zh) * | 2020-05-14 | 2020-09-15 | 中国海洋大学 | 一种具有增强免疫力功能的牡蛎肽虫草菌丝体组合物及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108210878A (zh) | 补肾生精的虫草雪莲多糖复合物 | |
CN108144040A (zh) | 补肾生精的虫草牡蛎肽复合物 | |
CN106913854A (zh) | 虫草多糖蛋白肽复合物及其应用 | |
CN106912953A (zh) | 虫草多糖复合物及其应用 | |
CN105296584A (zh) | 一种海洋生物养生保健肽制剂的制备方法 | |
CN105200105A (zh) | 一种牡蛎蛋白的保肝护肝肽制剂的制备方法 | |
CN103504444A (zh) | 一种灵芝竹荪固体饮料的制备方法 | |
CN109329834A (zh) | 一种枸杞抗疲劳保健食品及其制备方法 | |
CN101671620A (zh) | 绿龟茶酒及制备方法 | |
CN109043105A (zh) | 补肾生精的虫草海参肽压片糖果 | |
CN108148715A (zh) | 虫草多糖酒 | |
CN108477367A (zh) | 醒酒护肝的虫草低聚肽压片糖果 | |
CN105029553A (zh) | 一种果汁蛋钙中药保健饮料及其制备方法 | |
CN106520426A (zh) | 一种缓解体力疲劳的女性保健酒 | |
CN103251035A (zh) | 一种红椎菌粉的制备方法 | |
CN103462012B (zh) | 一种甲鱼保健液及制备方法 | |
CN108187032A (zh) | 虫草胶原蛋白肽片 | |
CN109043325A (zh) | 一种食用复合菌粉 | |
CN109077954A (zh) | 虫草面膜 | |
CN104738700B (zh) | 一种泥鳅护肝品及其制备方法 | |
JPH1075750A (ja) | にんにく系健康飲料 | |
CN108096570A (zh) | 具有排毒减肥功能的虫草蛋白肽片 | |
KR20160115628A (ko) | 이엠발효 기능성 커피 제조방법 | |
CN105475581B (zh) | 一种玫瑰茄保健袋泡茶及其制备方法 | |
CN103610123A (zh) | 一种海参和蛋白小球藻浆液制品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180629 |
|
RJ01 | Rejection of invention patent application after publication |